Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02501460 · ClinicalTrials.gov registry record · NA

Impact of Resistance Training-Protein Supplementation on Lean Muscle Mass in Childhood Cancer Survivors

A NA study of Cancer, sponsored by St. Jude Children's Research Hospital.

Completed
Registry status
NA
Development phase
130
Enrollment target
1
Study location

NCT02501460 is a NA study of Cancer that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 130 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02501460, a NA study of Cancer, has completed, sponsored by St. Jude Children's Research Hospital.

COMPLETED
Registry status
NA
Development phase
130 participants
Enrollment target
1
Study location

Study Summary

This study is being conducted because low lean muscle mass is prevalent among childhood cancer survivors. Lean muscle is the non-fatty muscle tissue that makes up part of the body's lean body mass. Low lean muscle mass is associated with loss of overall body strength, declining mobility and eventually, loss of independence. Among childhood cancer survivors, low lean muscle mass may contribute to reduced physical functioning and a sense of fatigue with exertion, limiting ability to participate in adequate physical activity. Loss of strength and a sense of fatigue with repeated movement make it difficult to participate in daily activities. Although there have not been exercise intervention studies among childhood cancer survivors specifically designed to evaluate the effects of resistance training on muscle mass, studies among individuals with chronic disease, including survivors of adult onset cancers, indicate that resistance exercise improves muscle mass, muscle strength, mobility, vitality and physical activity levels. Resistance training (weight lifting) is a form of physical activity that is designed to improve muscular fitness by exercising a muscle or a muscle group against external resistance. The purpose of the study is to evaluate the effects of resistance training combined with either a protein supplement or a sports drink on changes in lean muscle mass in young adults who were treated for childhood cancer. The sports drink, for this study, is considered a placebo.

Conditions Studied

Interventions

  • OTHER Placebo
  • OTHER Educational handouts
  • OTHER Resistance training
  • DIETARY_SUPPLEMENT Supplementation

Study Locations (1)

Tennessee

  • St. Jude Children's Research Hospital - Memphis

Trial Details

FieldValue
Enrollment Target 130 participants
Start Date 2015-08-17
Est. Completion 2018-01-30
Phase NA

What the Registry Record Tells You About NCT02501460

The ClinicalTrials.gov registry entry for NCT02501460 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (96% lower). The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.

NCT02501460 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT02501460 about?

NCT02501460 is a clinical study titled "Impact of Resistance Training-Protein Supplementation on Lean Muscle Mass in Childhood Cancer Survivors". This study is being conducted because low lean muscle mass is prevalent among childhood cancer survivors. Lean muscle is the non-fatty muscle tissue that makes up part of the body's lean body mass. Low lean muscle mass is associated with loss of overall body strength, declining mobility and eventual...

What is the current status of trial NCT02501460?

This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 2015-08-17. Estimated completion is 2018-01-30.

What conditions does trial NCT02501460 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT02501460?

The interventions under investigation include: Placebo (OTHER), Educational handouts (OTHER), Resistance training (OTHER), Supplementation (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT02501460?

This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02501460 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.